Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Cardiac Sciences
    • Drugs THAT prevent...

    Drugs THAT prevent sudden cardiac death in heart failure -Check it out

    Written by Medha Baranwal Baranwal Published On 2018-08-10T20:28:52+05:30  |  Updated On 10 Aug 2018 8:28 PM IST
    Drugs THAT prevent sudden cardiac death in heart failure -Check it out

    Which are the drugs THAT prevent sudden cardiac death in patients with reduced ejection fraction heart failure, has been specified by researchers after a review.


    Antialdosterone agents, beta-blockers, and combined ARBs (angiotensin receptor blockers) /neprilysin inhibitors are effective for the prevention of sudden cardiac death (SCD) in the patients with reduced ejection fraction (HFrEF) and Heart Failure, according to a review published in the journal BMJ Open.


    Muaamar Al-Gobari, Lausanne University Hospital (CHUV), Lausanne, Switzerland, and colleagues conducted the study to summarise and synthesize the current evidence regarding the effectiveness of drug interventions to prevent SCD and all-cause mortality in patients with Heart Failure and reduced ejection fraction (HFrEF).


    For the study, investigators searched multiple databases for studies in which the effectiveness of various pharmacologic interventions was evaluated in patients with HFrEF. They identified 41 reviews that included treatments such as beta-blockers, angiotensin-converting enzyme inhibitors (ACE-i), ARBs, anti-aldosterones or mineralocorticoid-receptor antagonists, amiodarone, other antiarrhythmics, combined ARB/neprilysin inhibitors, statins, and fish oil supplements.


    Also Read: 3D Virtual Heart to Predict Sudden Cardiac Death Risk

    Key Findings:

    • Beta-blockers (odds ratio [OR] 0.69 for SCD; 0.67 for all-cause mortality), anti-aldosterones (risk ratio [RR] 0.81 for SCD; 0.81 for all-cause mortality), and combined ARB/neprilysin inhibitors (RR 0.81 for SCD; 0.86 for all-cause mortality) were effective in preventing SCD and all-cause mortality.

    • ACE-i significantly reduced all-cause mortality but not SCD events (OR 0.91).

    • Neither ARBs nor statins appeared to be effective for reducing SCD or all-cause mortality.

    • The evidence for the efficacy of omega-3 fatty acids and antiarrhythmics was considered uncertain due to either conflicting or inconclusive evidence.

    • Amiodarone demonstrated a significant reduction in SCD events but not in all-cause mortality in newer studies, but a decline in both endpoints in older reviews.


    "This comprehensive overview of systematic reviews confirms that beta-blockers, antialdosterone agents, and combined ARB/neprilysin inhibitors are effective on SCD prevention but not ACE-i or ARBs," concluded the authors. "In patients with high risk of SCD, an alternative therapeutic strategy should be explored in future research."


    For more information follow the link: http://dx.doi.org/10.1136/bmjopen-2017-021108
    beta blockersBMJ Opencardiac arrestejection fractionHeartheart failureHFrEFmortalityMuaamar Al Gobarineprilysin inhibitorspreventionreviewSCDsudden cardiac death
    Source : With inputs from BMJ Open

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok